(“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing related sleep disorders and associated chronic health ...

A once-daily pill called sulthiame cut breathing interruptions during sleep by up to 47 percent in adults with obstructive ...

A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate ...

For decades, cumbersome CPAP machines have been the primary way to help people with sleep apnea. A range of new options has ...

Curious about CPAP therapy? Discover the types of CPAP machines and learn about how CPAP.com’s simple $99 at‑home sleep apnea ...

A European clinical trial finds the drug sulthiame can cut breathing interruptions in sleep apnea, offering hope for a ...

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...

Researchers conduct the first meta-analysis comparing hypnotics in OSA patients, finding most are safe but flagging temazepam ...

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...

Researchers believe that a drug used to treat childhood epilepsy may also be good for assisting with sleep apnea-related ...

Most hypnotics (sleep medications) for insomnia (sleep disorder) do not worsen obstructive sleep apnea but emphasize the need ...

Share on Pinterest A large new study suggests that treating sleep apnea could help lower a person’s risk of Parkinson’s disease. Image credit: Alvaro Lavin/Stocksy. People with obstructive sleep apnea ...